Your browser doesn't support javascript.
loading
Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial.
Chen, Li; Jiang, Yi-Zhou; Wu, Song-Yang; Wu, Jiong; Di, Gen-Hong; Liu, Guang-Yu; Yu, Ke-Da; Fan, Lei; Li, Jun-Jie; Hou, Yi-Feng; Hu, Zhen; Chen, Can-Ming; Huang, Xiao-Yan; Cao, A-Yong; Hu, Xin; Zhao, Shen; Ma, Xiao-Yan; Xu, Ying; Sun, Xiang-Jie; Chai, Wen-Jun; Guo, Xiaomao; Chen, Xizi; Xu, Yanhui; Zhu, Xiao-Yu; Zou, Jian-Jun; Yang, Wen-Tao; Wang, Zhong-Hua; Shao, Zhi-Ming.
Affiliation
  • Chen L; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
  • Jiang YZ; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Wu SY; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
  • Wu J; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Di GH; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
  • Liu GY; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Yu KD; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
  • Fan L; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Li JJ; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
  • Hou YF; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Hu Z; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
  • Chen CM; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Huang XY; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
  • Cao AY; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Hu X; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
  • Zhao S; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Ma XY; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
  • Xu Y; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Sun XJ; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
  • Chai WJ; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Guo X; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
  • Chen X; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Xu Y; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
  • Zhu XY; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Zou JJ; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
  • Yang WT; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Wang ZH; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
  • Shao ZM; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
Clin Cancer Res ; 28(13): 2807-2817, 2022 07 01.
Article in En | MEDLINE | ID: mdl-35247906
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms Type of study: Clinical_trials Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms Type of study: Clinical_trials Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: China